| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 147.70B | 164.00B | 136.73B | 134.91B | 130.87B |
| Gross Profit | 79.36B | 91.31B | 59.23B | 62.12B | 63.64B |
| EBITDA | 36.54B | 37.24B | -21.43B | 19.22B | 35.12B |
| Net Income | 19.05B | 24.19B | -28.68B | 8.86B | 30.53B |
Balance Sheet | |||||
| Total Assets | 333.24B | 394.19B | 335.71B | 348.94B | 340.57B |
| Cash, Cash Equivalents and Short-Term Investments | 103.05B | 92.80B | 71.40B | 97.73B | 78.30B |
| Total Debt | 15.43B | 48.41B | 44.51B | 45.16B | 28.27B |
| Total Liabilities | 92.46B | 141.31B | 115.68B | 114.95B | 95.66B |
| Stockholders Equity | 232.62B | 241.73B | 209.20B | 221.63B | 240.63B |
Cash Flow | |||||
| Free Cash Flow | 25.28B | 34.75B | -14.38B | 10.18B | 17.88B |
| Operating Cash Flow | 33.43B | 39.00B | -10.84B | 10.81B | 18.38B |
| Investing Cash Flow | 30.11B | -12.26B | -12.30B | 12.95B | -19.59B |
| Financing Cash Flow | -53.37B | -5.46B | -4.43B | -5.43B | -18.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥40.89B | 7.18 | ― | 4.06% | 9.32% | 243.34% | |
70 Outperform | ¥165.67B | 10.06 | 10.05% | 4.61% | 10.67% | 1.68% | |
69 Neutral | ¥296.04B | 14.97 | 17.98% | 2.52% | -9.94% | -21.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥118.44B | 78.66 | 3.38% | 2.38% | -5.49% | -82.16% | |
54 Neutral | ¥70.57B | 30.13 | 1.59% | 2.09% | -8.43% | -5.44% | |
42 Neutral | ¥18.31B | -4.19 | ― | ― | -17.15% | -70.83% |